0 likes | 5 Views
Every week, LSIu2019s Market Intelligence team dives into a different topic shaping the future of medical technology. From disruptive startups to fast-growing device segments, we connect the dots between clinical demand, market dynamics, and innovation pipelines. Hereu2019s what the LSI Market Intelligence team tracked this past month across electrophysiology (EP), transcatheter mitral valve replacement (TMVR), and the U.S. and APAC medtech markets. For more information visit here: https://www.lifesciencemarketresearch.com/insights/medtech-pulse-check-by-the-numbers<br>
E N D
Medtech Pulse Check, by the Numbers Every week, LSI’s Market Intelligence team dives into a different topic shaping the future of medical technology. From disruptive startups to fast-growing device segments, we connect the dots between clinical demand, market dynamics, and innovation pipelines. Here’s what the LSI Market Intelligence team tracked this past month across electrophysiology (EP), transcatheter mitral valve replacement (TMVR), and the U.S. and APAC medtech markets. Rewiring the Rhythm: Breakthroughs in Electrophysiology Heart rhythm disorder management is entering a new era. Once dominated by basic monitoring tools like the surface ECG, EP now encompasses a robust ecosystem of AI-powered diagnostics, leadless pacemakers, non-invasive ablation technologies, and real-time navigation software. Today, over 1.5 million pacemaker implantation procedures and 1.4 million cardiac ablation procedures are performed annually. Demand is growing, driven by technological refinement, an aging global population, and rising awareness of arrhythmias like atrial fibrillation (AFib). Disruptive Players Redefining EP AccurKardia CEO: Juan Jimenez Stage: Seed Raise to date: $3.2M Innovation: AI-driven ECG analytics for 13 heart rhythm disorders This blog is originally published here: https://www.lifesciencemarketresearch.com/insights/medtech-pulse-check-by-the-numbers